218 related articles for article (PubMed ID: 16013909)
1. Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial.
Kozarić-Kovacić D; Pivac N; Mück-Seler D; Rothbaum BO
J Clin Psychiatry; 2005 Jul; 66(7):922-7. PubMed ID: 16013909
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features.
Kozaric-Kovacic D; Pivac N
Int J Neuropsychopharmacol; 2007 Apr; 10(2):253-61. PubMed ID: 16945162
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder.
Pivac N; Kozaric-Kovacic D; Muck-Seler D
Psychopharmacology (Berl); 2004 Oct; 175(4):451-6. PubMed ID: 15064916
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy of treatment-resistant combat-related posttraumatic stress disorder with psychotic features.
Pivac N; Kozarić-Kovacić D
Croat Med J; 2006 Jun; 47(3):440-51. PubMed ID: 16758523
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
Addington DE; Pantelis C; Dineen M; Benattia I; Romano SJ
J Clin Psychiatry; 2004 Dec; 65(12):1624-33. PubMed ID: 15641867
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms.
Hamner MB; Faldowski RA; Ulmer HG; Frueh BC; Huber MG; Arana GW
Int Clin Psychopharmacol; 2003 Jan; 18(1):1-8. PubMed ID: 12490768
[TBL] [Abstract][Full Text] [Related]
8. Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504.
Krystal JH; Pietrzak RH; Rosenheck RA; Cramer JA; Vessicchio J; Jones KM; Huang GD; Vertrees JE; Collins J; Krystal AD;
J Clin Psychiatry; 2016 Apr; 77(4):483-91. PubMed ID: 26890894
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial.
Krystal JH; Rosenheck RA; Cramer JA; Vessicchio JC; Jones KM; Vertrees JE; Horney RA; Huang GD; Stock C;
JAMA; 2011 Aug; 306(5):493-502. PubMed ID: 21813427
[TBL] [Abstract][Full Text] [Related]
10. Risperidone in the treatment of elderly patients with psychotic disorders.
Madhusoodanan S; Brecher M; Brenner R; Kasckow J; Kunik M; Negrón AE; Pomara N
Am J Geriatr Psychiatry; 1999; 7(2):132-8. PubMed ID: 10322240
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder.
Bartzokis G; Lu PH; Turner J; Mintz J; Saunders CS
Biol Psychiatry; 2005 Mar; 57(5):474-9. PubMed ID: 15737661
[TBL] [Abstract][Full Text] [Related]
12. A trial of low doses of risperidone in the treatment of patients with first-episode schizophrenia, schizophreniform disorder, or schizoaffective disorder.
Huq ZU;
J Clin Psychopharmacol; 2004 Apr; 24(2):220-4. PubMed ID: 15206670
[TBL] [Abstract][Full Text] [Related]
13. Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.
Villarreal G; Calais LA; Cañive JM; Lundy SL; Pickard J; Toney G
Psychopharmacol Bull; 2007; 40(2):6-18. PubMed ID: 17514183
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive risperidone treatment and sleep symptoms in combat veterans with chronic PTSD.
David D; De Faria L; Mellman TA
Depress Anxiety; 2006; 23(8):489-91. PubMed ID: 16845653
[TBL] [Abstract][Full Text] [Related]
15. Symptom structure and severity: a comparison of responses to the positive and negative syndrome scale (PANSS) between patients with PTSD or schizophrenia.
Stefanovics EA; Krystal JH; Rosenheck RA
Compr Psychiatry; 2014 May; 55(4):887-95. PubMed ID: 24602497
[TBL] [Abstract][Full Text] [Related]
16. A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group.
Davidson M; Harvey PD; Vervarcke J; Gagiano CA; De Hooge JD; Bray G; Dose M; Barak Y; Haushofer M
Int J Geriatr Psychiatry; 2000 Jun; 15(6):506-14. PubMed ID: 10861916
[TBL] [Abstract][Full Text] [Related]
17. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
[TBL] [Abstract][Full Text] [Related]
18. Effect of risperidone on behavioral and psychological symptoms and cognitive function in dementia.
Rainer MK; Masching AJ; Ertl MG; Kraxberger E; Haushofer M
J Clin Psychiatry; 2001 Nov; 62(11):894-900. PubMed ID: 11775050
[TBL] [Abstract][Full Text] [Related]
19. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.
Rothbaum BO; Killeen TK; Davidson JR; Brady KT; Connor KM; Heekin MH
J Clin Psychiatry; 2008 Apr; 69(4):520-5. PubMed ID: 18278987
[TBL] [Abstract][Full Text] [Related]
20. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
Hirschfeld RM; Keck PE; Kramer M; Karcher K; Canuso C; Eerdekens M; Grossman F
Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
